Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 10 | uM | 7 | 312.50 | 133.67 | 222.00 | 281.00 | 0.7900 | 0.6053 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 232.00 | 281.00 | 0.8256 | 0.6726 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 313.00 | 281.00 | 1.1139 | 1.2117 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 305.00 | 281.00 | 1.0854 | 1.1589 |
| BT-20 | Erlotinib | 1 | uM | 7 | 312.50 | 133.67 | 323.00 | 281.00 | 1.1495 | 1.2775 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 296.00 | 281.00 | 1.0534 | 1.0994 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 3.00 | 281.00 | 0.0107 | -0.9710 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 2.00 | 281.00 | 0.0071 | -0.9802 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 275.00 | 281.00 | 0.9787 | 0.9601 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 247.00 | 281.00 | 0.8790 | 0.7733 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 312.50 | 133.67 | 216.00 | 281.00 | 0.7687 | 0.5648 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 232.00 | 281.00 | 0.8256 | 0.6726 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 133.67 | 317.00 | 281.00 | 1.1281 | 1.2381 |
| BT-20 | 17-AAG | 1 | uM | 7 | 312.50 | 133.67 | 135.00 | 281.00 | 0.4804 | 0.0093 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 312.50 | 133.67 | 304.00 | 281.00 | 1.0819 | 1.1523 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 312.50 | 133.67 | 140.00 | 281.00 | 0.4982 | 0.0441 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 274.00 | 281.00 | 0.9751 | 0.9535 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 243.00 | 281.00 | 0.8648 | 0.7465 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 312.50 | 133.67 | 153.00 | 281.00 | 0.5445 | 0.1343 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 298.00 | 281.00 | 1.0605 | 1.1127 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 255.00 | 281.00 | 0.9075 | 0.8268 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 312.50 | 133.67 | 272.00 | 281.00 | 0.9680 | 0.9402 |
| BT-20 | Lapatinib | 10 | uM | 7 | 312.50 | 133.67 | 145.00 | 281.00 | 0.5160 | 0.0789 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 144.00 | 281.00 | 0.5125 | 0.0719 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 244.00 | 281.00 | 0.8683 | 0.7532 |